Charles River Laboratories | CRL - PE价格收益



金融业
股票价格
USD
资产
USD 7.53B
现金及等价物
USD 192.03M
销售成本
USD 655.29M
流动资产
USD 1.53B
流动负债
USD 1.13B
债务
USD 3.06B
EBIT
USD 119.89M
EBITDA
USD 272.95M
员工
18.6K
EPS每股收益
USD 3.02
股本和储备
USD 2.84B
销售毛利
USD 348.79M
债务利息支出
USD 30.34M
利息收入
USD -0.03
贷款资金
USD 2.62B
市值
USD 13.56B
净收入
USD -1.48M
营业费用
USD 2.84B
营业利润
USD 119.89M
普通股股本
USD 47.73M
PE价格收益
58.27
税前利润
USD -29.94M
销售收入
USD 1B
销售和管理费用
USD 228.9M
股票
USD 346.26M
贸易债权人
USD 140.98M
应收帐款人
USD 711.76M


Pe 更改 日
Agilent 20.53 4.51 2026-03
Align Technology 21.8 0.98 2026-06
Bio-Rad Laboratories 10.01 15.27 2026-03
Bruker 46.54 9.74 2026-06
Cardinal Health 30.4 5.87 2026-03
Charles River Laboratories 58.27 29 2026-06
Cigna 11.69 0.34 2026-06
CVS Health 12.51 2.86 2026-06
Danaher 32.68 3.4 2026-06
Dentsply International 20.31 9.68 2026-03
Elevance Health 17.11 4.71 2026-06
Humana 24.28 13.21 2026-06
Illumina 48.98 16.53 2026-06
Incyte 14.45 0.9 2026-06
Intrexon 7.54 221.44 2021-12
IQVIA Holdings 21.45 2.08 2026-06
Laboratory Of America 20.47 5.04 2026-06
Lakefront Biotherapeutics 2.54 0.6 2026-03
Lonza 34.34 2.58 2025-12
McKesson 20.36 4.61 2026-06
Merck 12.74 7.82 2026-03
Mettler Toledo International 27.29 0.04 2026-06
Novartis 22.41 2.24 2026-06
Pfizer 11.48 2.16 2026-06
Quest Diagnostics 21.23 1.17 2026-06
Revvity 36.47 5.68 2026-06
Thermo Fisher Scientific 26.4 1.31 2026-06
United Therapeutics 19.15 1.27 2026-06
UnitedHealth 20.96 5.68 2026-06
Veradigm 11.15 4.63 2022-09
Waters 66.69 36.94 2026-06
West Pharmaceutical Services 42.63 10.64 2026-06